HOME >> BIOLOGY >> NEWS
Food safety: French discovery explains how Listeria penetrates the body, and may suggest new drug delivery strategies

e to enter the bloodstream, where it disseminates to the central nervous system and the placenta. But, the molecular events that allow Listeria to cross the intestinal barrier have remained a mystery--until now.

In previous studies, Cossart and her colleagues--including Jean Louis Gaillard, Jerme Mengaud and Marc Lecuit--had shown that a protein on Listeria's surface called "internalin" interacts with a receptor, E-cadherin found on cultured cells derived from the intestine. Similar to a key-and-lock system, internalin interacts with E-cadherin to promote the entry of Listeria into intestinal cells. Listeria can then cross the intestine and pass into the bloodstream, scientists said.

Studying this mechanism in animals proved difficult, however, because rats and mice produce a form of cadherin that doesn't bind with internalin. Fortunately, guinea pigs generate a suitable version of the protein, making these animals a useful model for studying oral Listeria infection. The difference between the two forms of cadherin, Cossart explained, is a single amino acid in the 16th position of cadherin's molecular chain.

For their latest Science study, Lecuit et al.(Cossart's team in collaboration with transgenesis expert Charles Babinet and other scientists at the Pasteur Institute), investigated oral infection mechanisms within guinea pigs and transgenic mice, which had been genetically modified to express the human version of cadherin in the intestine. Animals received oral doses of both wild-type Listeria, as well as a mutant, internalin-free version of the bacterium. Wild Listeria, featuring the internalin protein, proved fatal in most cases, whereas the mutant strain caused no deaths and failed to cross the intestine and invade organ tissues.

Thus, the French investigation identifies a "virulence factor" or molecular mechanism by which Listeria causes disease, thereby addressing a key recommenda
'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
31-May-2001


Page: 1 2 3 4

Related biology news :

1. Bones from French cave show Neanderthals, Cro-Magnon hunted same prey
2. Fire on French Riviera
3. Smaller food portions may explain the French paradox of rich foods and a svelte population
4. ESA providing Kyoto estimates of French Guianas tropical forests
5. Researchers develop white wine with cholesterol-lowering benefits, discover Israeli wines healthier than French wines
6. Beyond the French paradox
7. Study seems to show why French suffer less heart disease, cancer
8. The Reason The French Have Low Levels Of Heart Disease
9. New Technology Turns French Fry Oil Into Diesel Fuel
10. French Researchers Breed Flightless Ladybirds As Pest-Killers
11. Very Fruitful Collaboration Between French And German Scientists Yields Unusual Insights Into The Structure Of Membrane Proteins

Post Your Comments:
(Date:7/21/2015)... YORK , July 21, 2015 ... systems, as seen in the recent U.S. Office ... a solution to the infosec conundrum, but developers ... is stored. To address this dilemma, Biometrics-as-a-Service provider ... its Biometric Tokenization SDK for third party integration. ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
(Date:7/29/2015)... YORK , July 29, 2015  Therapath ... testing, announces increased partnerships with VA and Military ... Epidermal Nerve Fiber Density (ENFD) and Sweat Gland ... small fiber neuropathy ( https://therapath.com/skin ). ... Nerve Fiber Density (ENFD) on punch skin biopsy ...
(Date:7/29/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... optimized Erk inhibitor molecule for development, thus achieving ... new class of potential cancer therapies. ... for therapeutic intervention in cancer. Recently approved compounds ... B-Raf and Mek inhibitors. Erk inhibitors may be ...
(Date:7/29/2015)... ... July 29, 2015 , ... Rainbow Scientific, Inc. (RSI), a ... availability of BI’s line of human mesenchymal stem cell (hMSC) differentiation media, ... offer a complete system for multipotency evaluation of hMSCs and reliable induction of ...
(Date:7/28/2015)... ... ... 530 sample changer for vials can be used with Anton Paar density meters, viscometers ... mPas (internal air) up to 36,000 (external air) – and can process up to 71 ... is its removable magazine, which is easily lifted off its hub and carried by hand ...
Breaking Biology Technology:Neuropathology services for VA and Military health systems 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3New Moves in Automatic Sample Handling: Introducing Xsample 530 2
Cached News: